EGFR and lung carcinoma: Wang et al. (Wang H. et al., 2019) developed a predictive model to distinguish between EGFR with exon 21 mutation and wild-type lung cancer, achieving accuracy, sensitivity, and specificity rates of 0.87, 0.946, and 0.738, respectively.